Global Newborn and Prenatal Genetic Testing Market Research Report 2024
Newborn and prenatal genetic testing is to judge the underlying genetic disease of the newborn and fetus.
According to MRAResearch’s new survey, global Newborn and Prenatal Genetic Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Newborn and Prenatal Genetic Testing market research.
Due to the increased prevalence of genetic diseases and chromosomal abnormalities, the need for early screening for prenatal and newborn defects has increased. According to the Centers for Disease Control and Prevention (CDC), birth defects occur in about 3% of the total number of live births worldwide, leading to infant death.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Newborn and Prenatal Genetic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Perkin Elmer
Verinata Health
Sequenom, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Natera, Inc.
Illumina, Inc.
Ariosa Diagnostics
BGI
CapitalBio MedLab
Segment by Type
PCR
FISH
aCGH
NIPT
MSS
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Newborn and Prenatal Genetic Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn and Prenatal Genetic Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 PCR
1.2.3 FISH
1.2.4 aCGH
1.2.5 NIPT
1.2.6 MSS
1.3 Market by Application
1.3.1 Global Newborn and Prenatal Genetic Testing Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn and Prenatal Genetic Testing Market Perspective (2018-2033)
2.2 Newborn and Prenatal Genetic Testing Growth Trends by Region
2.2.1 Global Newborn and Prenatal Genetic Testing Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Newborn and Prenatal Genetic Testing Historic Market Size by Region (2018-2023)
2.2.3 Newborn and Prenatal Genetic Testing Forecasted Market Size by Region (2024-2033)
2.3 Newborn and Prenatal Genetic Testing Market Dynamics
2.3.1 Newborn and Prenatal Genetic Testing Industry Trends
2.3.2 Newborn and Prenatal Genetic Testing Market Drivers
2.3.3 Newborn and Prenatal Genetic Testing Market Challenges
2.3.4 Newborn and Prenatal Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn and Prenatal Genetic Testing Players by Revenue
3.1.1 Global Top Newborn and Prenatal Genetic Testing Players by Revenue (2018-2023)
3.1.2 Global Newborn and Prenatal Genetic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Newborn and Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn and Prenatal Genetic Testing Revenue
3.4 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio
3.4.1 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn and Prenatal Genetic Testing Revenue in 2022
3.5 Newborn and Prenatal Genetic Testing Key Players Head office and Area Served
3.6 Key Players Newborn and Prenatal Genetic Testing Product Solution and Service
3.7 Date of Enter into Newborn and Prenatal Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn and Prenatal Genetic Testing Breakdown Data by Type
4.1 Global Newborn and Prenatal Genetic Testing Historic Market Size by Type (2018-2023)
4.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Type (2024-2033)
5 Newborn and Prenatal Genetic Testing Breakdown Data by Application
5.1 Global Newborn and Prenatal Genetic Testing Historic Market Size by Application (2018-2023)
5.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Newborn and Prenatal Genetic Testing Market Size (2018-2033)
6.2 North America Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Newborn and Prenatal Genetic Testing Market Size by Country (2018-2023)
6.4 North America Newborn and Prenatal Genetic Testing Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn and Prenatal Genetic Testing Market Size (2018-2033)
7.2 Europe Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Newborn and Prenatal Genetic Testing Market Size by Country (2018-2023)
7.4 Europe Newborn and Prenatal Genetic Testing Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size (2018-2033)
8.2 Asia-Pacific Newborn and Prenatal Genetic Testing Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn and Prenatal Genetic Testing Market Size (2018-2033)
9.2 Latin America Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2018-2023)
9.4 Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size (2018-2033)
10.2 Middle East & Africa Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perkin Elmer
11.1.1 Perkin Elmer Company Detail
11.1.2 Perkin Elmer Business Overview
11.1.3 Perkin Elmer Newborn and Prenatal Genetic Testing Introduction
11.1.4 Perkin Elmer Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.1.5 Perkin Elmer Recent Development
11.2 Verinata Health
11.2.1 Verinata Health Company Detail
11.2.2 Verinata Health Business Overview
11.2.3 Verinata Health Newborn and Prenatal Genetic Testing Introduction
11.2.4 Verinata Health Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.2.5 Verinata Health Recent Development
11.3 Sequenom, Inc.
11.3.1 Sequenom, Inc. Company Detail
11.3.2 Sequenom, Inc. Business Overview
11.3.3 Sequenom, Inc. Newborn and Prenatal Genetic Testing Introduction
11.3.4 Sequenom, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.3.5 Sequenom, Inc. Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Detail
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Introduction
11.4.4 Agilent Technologies, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Detail
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Natera, Inc.
11.6.1 Natera, Inc. Company Detail
11.6.2 Natera, Inc. Business Overview
11.6.3 Natera, Inc. Newborn and Prenatal Genetic Testing Introduction
11.6.4 Natera, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.6.5 Natera, Inc. Recent Development
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Detail
11.7.2 Illumina, Inc. Business Overview
11.7.3 Illumina, Inc. Newborn and Prenatal Genetic Testing Introduction
11.7.4 Illumina, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.7.5 Illumina, Inc. Recent Development
11.8 Ariosa Diagnostics
11.8.1 Ariosa Diagnostics Company Detail
11.8.2 Ariosa Diagnostics Business Overview
11.8.3 Ariosa Diagnostics Newborn and Prenatal Genetic Testing Introduction
11.8.4 Ariosa Diagnostics Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.8.5 Ariosa Diagnostics Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Newborn and Prenatal Genetic Testing Introduction
11.9.4 BGI Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.9.5 BGI Recent Development
11.10 CapitalBio MedLab
11.10.1 CapitalBio MedLab Company Detail
11.10.2 CapitalBio MedLab Business Overview
11.10.3 CapitalBio MedLab Newborn and Prenatal Genetic Testing Introduction
11.10.4 CapitalBio MedLab Revenue in Newborn and Prenatal Genetic Testing Business (2018-2023)
11.10.5 CapitalBio MedLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details